Brazilian diagnostic tests: essential health supplies for COVID-19 syndromic surveillance

Author:

Cavalcante Fabrício Vieira1ORCID,Oliveira Aimê1ORCID,Araujo Sidclei Queiroga de1ORCID,Pacheco Christina2ORCID,Sacco Ruth da Conceição Costa e Silva1ORCID

Affiliation:

1. Universidade de Brasília, Brasil

2. Universidade Estadual do Rio Grande do Norte, Brasil

Abstract

ABSTRACT There is much evidence suggesting that mitigating the COVID-19 pandemic requires syndromic surveillance and isolation of suspected/confirmed cases. The availability of diagnostic tests in the Brazilian Unified Health System (SUS) is essential, which could be facilitated by national sovereignty in development and production, considering the high demand/lack of supply in the international market. This study identified the stages of translational research into diagnostic tests for COVID-19 in Brazil, verifying their geographic distribution, among other indicators. A cross-sectional, exploratory study based on a public database with 789 Research, Development, and Innovation (RD&I) projects regarding COVID-19, complemented by other searches, including the researchers’ curricula (CVLattes). There were 89 diagnostic test projects in the database. In 45 cases, it was possible to obtain additional information to classify them according to the translational research stages. Fifteen innovations that reached the T3 stage were identified, with their products incorporated into clinical protocols in healthcare, even considering the deep budget restrictions in RD&I. Brazil has the potential to develop and implement technological products in the field of diagnostic tests for SARS-CoV-2. Public health RD&I policies need to be prioritized to expand national and international cooperation to promote effective national autonomy in syndromic surveillance and population health.

Publisher

FapUNIFESP (SciELO)

Subject

General Medicine

Reference61 articles.

1. Folha informativa sobre Covid-19,2021

2. Painel de casos de doença pelo coronavírus 2019 (Covid-19) no Brasil pelo Ministério da Saúde. Versão v2.0,2021

3. The influence of the U.S. response to Covid-19 in global health;Leineweber FV;Ciênc. Saúde Colet.,2021

4. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review;Nussbaumer-Streit B;Cochrane Database of Systematic Reviews,2020

5. Public health surveillance in the United States;Thacker SB;Epidemiologic Reviews,1988

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3